MDxHealth SA Files 6-K Report for March 2024
Ticker: MDXH · Form: 6-K · Filed: Mar 6, 2024 · CIK: 1872529
| Field | Detail |
|---|---|
| Company | Mdxhealth SA (MDXH) |
| Form Type | 6-K |
| Filed Date | Mar 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, press-release
TL;DR
MDxHealth SA filed a 6-K for March 2024, attaching a press release. Stay tuned for updates.
AI Summary
On March 6, 2024, MDxHealth SA announced the issuance of a press release, attached as Exhibit 99.1 to this 6-K filing. The press release details the company's activities for the month of March 2024. The company is a foreign private issuer filing under the 1934 Securities Exchange Act.
Why It Matters
This filing provides an update on MDxHealth SA's activities, which is crucial for investors to stay informed about the company's ongoing operations and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- MDxHealth SA (company) — Registrant
- March 6, 2024 (date) — Date of press release issuance
- Exhibit 99.1 (document) — Attached press release
- 001-40996 (other) — Commission File Number
FAQ
What is the purpose of this 6-K filing?
The purpose of this 6-K filing is to report on the activities of MDxHealth SA, a foreign private issuer, for the month of March 2024, by attaching a press release as Exhibit 99.1.
When was the press release attached to this filing issued?
The press release attached to this filing was issued on March 6, 2024.
What is the Commission File Number for MDxHealth SA?
The Commission File Number for MDxHealth SA is 001-40996.
Does MDxHealth SA file annual reports under Form 20-F or 40-F?
MDxHealth SA files annual reports under Form 20-F, as indicated by the checkmark next to it.
Where is MDxHealth SA's principal executive office located?
MDxHealth SA's principal executive office is located at CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium.
Filing Stats: 272 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-03-06 17:04:12
Filing Documents
- ea0201215-6k_mdxhealth.htm (6-K) — 10KB
- ea0201215ex99-1_mdxhealth.htm (EX-99.1) — 91KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- ex99-1_002.jpg (GRAPHIC) — 2KB
- 0001213900-24-020488.txt ( ) — 109KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: March 6, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2